The RNA Society's Next Meeting

RNA 2017, The Twenty-second Annual Meeting of the RNA Society

The twenty-second annual meeting of the RNA Society will be held May 30 – June 3, 2017 in Prague, Czech Republic

Organizers:
Andrea Barta, Medical University of Vienna, Vienna
Rachel Green, Johns Hopkins University, School of Medicine, Baltimore
Christopher Lima, Sloan-Kettering Institute, New York
Ron Micura, Leopold Franzens University, Innsbruck
Petr Svoboda, Institute of Molecular Genetics ASCR, Prague
Yukihide Tomari, University of Tokyo IMCB, Tokyo

Other Meetings and Conferences

Microsymposium on Small RNA Biology

Scientific Organizers:

Stefan Ameres, IMBA, Vienna, Austria
Julius Brennecke, IMBA, Vienna, Austria
Luisa Cochella, IMP, Vienna, Austria
Javier Martinez, MFPL, Vienna, Austria
Michael Nodine, GMI, Vienna, Austria

The Microsymposium is a three-day international conference that brings together young scientists, junior and senior group leaders, and company representatives from all over the world to present and discuss their latest findings in the exciting field of small RNAs. The Microsymposium was founded in 2005 and has established itself as the major small RNA meeting in Europe. It is organized by the three research institutions IMBA, IMP, and GMI, as well as by the RNA community of the Vienna Biocenter.

The conference includes a PhD Student Workshop. From the submitted abstracts, 8-10 students will be selected as speakers. Travel and accommodation for these students will be covered.

The Microsymposium is entirely financed by scientific societies, leading journals, biotech companies, the city of Vienna, and the research institutions IMBA, IMP, and GMI. These generous contributions make the Microsymposium a registration-free meeting for all its participants.

This year, the Microsymposium will take place just a few days before the RNA Society Meeting in Prague, which will begin on May 30th, to facilitate traveling for people who plan to attend both.

Deadlines:
• Abstract submission: April 15, 2017
• Registration: May 15, 2017

For more information, including a full list of speakers, and to register, please visit:
http://www.imba.oeaw.ac.at/news-events/events/microsymposium/

Hallmarks of Cancer: Focus on RNA

Accumulating evidences support the importance of RNA biology in the hallmarks of cancer. Post-transcriptional steps of gene expression (pre-mRNA splicing, polyadenylation, stability, translation, localization and modifications) as well as the functions of non-coding RNAs are increasingly diverse. It is therefore challenging to comprehend this complexity in the context of cancer.

The internationally renowned experts invited to this symposium will present the recent advances in our understanding of RNA biology in cancer. This will be complemented by at least 10 selected talks, as well as poster presentations.

The symposium is intended to bring together RNA and cancer biologists. It is expected that the small size of the attendance (max. 150) will foster stimulating discussions that will lead to innovative collaborations.

Sessions:
– Regulators of RNA metabolism as oncoproteins and tumor suppressors
– Oncogenic signalling to RNAs and anti-cancer targeted therapies
– RNA modifications in cancer development and progression
– Extracellular RNA trafficking
– RNA-based reprograming of cancer cell metabolism
– Immune response and RNA biology

Organizers:
Martin Dutertre (Curie institute, FR), David Stanek (IMG, CZ), Petr Svoboda (IMG, CZ), Stéphan Vagner (Curie institute, FR), Juan Valcarcel (CRG, ES), Sandra Wolin (NCI, USA)

Registration fee: 150 EurosRegistration and full payment due no later than March 20, 2017.

The registration fees include access to sessions, coffee breaks, two dinners (Sunday and Monday) and two lunches (Monday and Tuesday). Payment must be made in full at the time of registration only by Credit Card.

Abstracts are welcome on all scientific topics related to the symposium and must be submitted electronically by March 20, 2017. Those who wish to submit an abstract must first register to attend the conference. Selection of abstracts for oral (at least 10) and poster presentations will be made by the organizers. Acceptance of abstracts and their status (talk/poster) will be sent by email no later than April 20, 2017. The audience will be limited to 150 participants.

Website: https://www.weezevent.com/cancer-rna-2017

EMBL Course: Whole Transcriptome Data Analysis

Benes, R. Calogero

The course participants will learn how to use BioConductor software and Illumina BaseSpace Cloud apps. In the first three days, the course covers various topics using the oneChannelGUI graphical interface. The last day is dedicated to providing the basics to move from the use of the graphical environment to command line. The basics of R scripting will be described and some of the workflows used in the first three days will be dissected and executed using command line approach. All computers for hands-on exercises will be provided along with demo data sets.

Audience

This course was developed for biologists as the intended audience, particularly for those already with basic knowledge of massively parallel sequencing (MPS). However, R-coding skills and deep knowledge of statistics are not necessary for attendance.

http://www.embl.de/training/events/2017/DAT17-01/index.html

2nd International Aegean Conference on the Long and the Short of Non-Coding RNAs

Organizers:
Judy Lieberman
(Harvard Medical School)
Zissimos Mourelatos (University of Pennsylvania)
Andrei Thomas-Tikhonenko (Children’s Hospital of Philadelphia)

The goal of this conference is two-fold. One is to review recent advances in non-coding RNA biology, from biosynthesis to function and from piRNAs to spliceosomes. The second is to discuss the use of therapeutic non-coding RNAs (asRNAs, siRNAs, miRNA mimics and antagomirs, sgRNAs of the CRISPR/Cas9 system, etc.) as tools to correct faulty gene expression in human disease.

Scientific Sessions:
Systems biology of ncRNAs | microRNA biogenesis and regulation | short RNAs in development & disease | mRNA metabolism 1 | mRNA metabolism 2 | lncRNAs in development & disease | Long and short ncRNAs in cancer | Genome editing and RNA therapeutics

Confirmed Speakers:
Reuven Agami
,  The Netherlands Cancer Institute | Iannis Aifantis, New York University | David Bartel, Massachusetts Institute of Technology | Robert Blelloch, University of California San Francisco | Javier Caceres, MRC – University of Edinburgh | Howard Chang, Stanford University | Emmanuelle Marie Charpentier, Max Planck Institute for Infection Biology – Berlin | David Corey, UT Southwestern Medical Center | Beverly Davidson, Children’s Hospital of Philadelphia | Gideon Dreyfus, University of Pennsylvania | Greg Goodall, Centre for Cancer Biology Adelaide | Richard Gregory, Boston Children’s Hospital | Chuan He, University of Chicago | Lin He, University of California Berkeley | Maite Huarte, University of Navarra | Elisa Izaurralde, Max Planck Institute Tubingen | Marianthi Kiriakidou, Thomas Jefferson University | Judy Lieberman, Harvard Medical School | Kristen Lynch, University of Pennsylvania | Lynne Maquat, University of Rochester | Chris Marine, VIB & University of Leuven | Christine Mayr,         Memorial Sloan-Kettering Cancer Center | Joshua Mendell, UT Southwestern Medical Center | Zissimos Mourelatos, University of Pennsylvania | Nikolaus Rajewsky, Max Delbrück Center – Berlin | Isidore Rigoutsos, Thomas Jefferson University | Martine Simonelig, Institute of Human Genetics Montpellier | Andrei Thomas-Tikhonenko,  Children’s Hospital of Philadelphia | Andrea Ventura, Memorial Sloan Kettering Cancer Center

Additional short talks will be selected from proffered abstracts

Important Deadlines:

  • March 1, 2017: Abstract Submission
  • March 1, 2017: Discounted Registration
  • March 15, 2017: Travel Award Application

For more information and to register, please visit:
http://www.aegeanconferences.org/src/App/conferences/view/116

EMBO conference: Eukaryotic RNA turnover

Recent research has shown that RNA decay makes major contributions to biological regulation and cellular surveillance in eukaryotes. Fundamental RNA turnover pathways now being studied at the atomic level are conserved among yeasts, animals and plants, while each system also exhibits diversification. Central themes include regulation of mRNA turnover by AU-rich elements, and the effects of microRNAs on RNA decay and translation. In addition, numerous mechanisms eliminate RNAs that fail quality control checkpoints. This EMBO conference will also be a major forum for discussion of the latest findings relating to altered RNA turnover in disease, and the identification of potential therapeutic targets.

Session topics:

  • The machinery of RNA turnover
  • RNA quality control
  • RNA turnover and regulation of gene expression
  • miRNA-mediated mRNA regulation
  • Trans-acting factors and mRNA turnover
  • Global regulation of RNA turnover
  • RNA turnover and disease
  • 5′-3′ RNA turnover
  • Regulation of mRNA turnover

Speakers:
Stefan Ameres, Institute of Molecular Biotechnology, Vienna, Austria.
Cecilia Arraiano, Universidade Nova de Lisboa, Portugal.
Cécile Bousquet-Antonelli, University of Perpignan, France.
Mordechai Choder, Technion, Haifa, Israel.
Christine Clayton, University of Heidelberg, Germany.
Elena Conti, Max Planck Institute of Biochemistry, Martinsreid, Germany.
Myriam Gorospe, NIH, Baltimore, USA.
Pam Green, University of Delaware, USA.
Helge Grosshans, Friedrich Miescher Institute, Basel, Switzerland.
Matthias Hentze, EMBL, Heidelberg, Germany.
Torben Jensen, University of Aarhus, Denmark.
Joanna Kufel, University of Warsaw, Poland.
Elisa Izaurralde, Max Planck Institute, Tübingen, Germany.
Jack Keene, Duke University, USA.
Mike Kiledjian, Rutgers University, USA.
Domenico Libri, CNRS / Institut Jacques Monod, Paris, France.
Chris Lima, HHMI / Sloan-Kettering Institute, USA.
Lynne Maquat, University of Rochester, USA.
Sarah Newbury, University of Sussex, UK.
Lori Passmore, MRC LMB, University of Cambridge, UK.
Sébastien Pfeffer, CNRS / University of Strasbourg, France.
David Port, University of Colorado, USA.
Olivia Rissland, University of Toronto, Canada.
Bertrand Séraphin, IGBMC, Strasbourg, France.
Georg Stoecklin, University of Heidelberg, Germany.
Stepanka Vanacova, CEITEC / Masaryk University, Brno, Czech Republic.
Lidia Vasilieva, University of Oxford, UK.
Steve West, University of Sheffield, UK.
Jeff Wilusz, Colorado State University, USA.

Scientific Organizers:
Chris Norbury, University of Oxford, UK.
Sarah Newbury, University of Sussex, UK.
Cecilia Arraiano, ITQB, Portugal.

Website:
http://meetings.embo.org/event/17-rna-turnover

Deadlines:
Registration deadline: 28th April 2017.
Abstract submission deadline: 28th April 2017.
Chosen participants will be notified by 5th May, 2017. Payment deadline 5th May 2017.

ISMB 2017

The RNA-SIG brings together experts in computational and experimental aspects of research in RNA Biology. The meeting focuses on the development of computational and high-throughput experimental methods, and the application of such methods to break new grounds in the study of RNA biology and disease. Aspects of RNA Biology and related computational methods include alternative splicing, alternative polyadenylation (APA), post-transcriptional regulation, RNA 2D/3D structure, and the expression and function of non-coding RNAs, such as micro-RNAs (miRNAs) and long non-coding RNAs (lncRNA).

If you would like to submit an abstract for an oral or poster presentation for the RNA-SIG please use this link.

Upcoming Deadlines

  • April 13: Oral abstract submission deadline.
  • May 10: Notification of accepted oral abstracts.
  • May 15: Poster abstract submission deadline.
  • May 31: Notification of accepted poster abstracts.
  • June 15: Early registration ends.
  • July 21: RNA SIG Meeting.

Organizing Committee
Klemens Hertel,
University of California Irvine, CA, USA
Yoseph Barash, University of Pennsylvania, PA, USA
Eduardo Eyras, Pompeu Fabra University, Barcelona, Spain

EMBO Conference: RNA localisation and local translation

Website:
http://meetings.embo.org/event/17-rna-localisation

Deadlines:
Registration deadline: 31 March 2017
Abstract submission deadline: 23 March 2017 Chosen participants will be notified by 27 March 2017 Payment deadline: 15 April 2017

About the Conference
RNA localization and local translation are essential for the functional polarization of cells, impacting on numerous physiological processes. They lie at the heart of cellular, developmental and neurobiology and are of principal importance in the execution of polarised cell functions, in health and disease.
This third EMBO Conference will be the latest in a series that has taken place biennially for over twenty years, initially in the US and, thanks to EMBO, in recent years alternating between the US and Europe. The meeting brings together leading scientists studying RNA transport, translation, stability and decay, and how cells harness RNA regulation to achieve tight spatial and temporal control of protein expression. The participants will include established investigators, junior faculty, postdocs and students employing diverse model systems and the entire range of modern biological approaches, including genetics, in vivo imaging, high throughput transcriptomics and proteomics, biochemistry and structural biology. This EMBO Conference is a forum where the latest technologies in RNA and protein detection and imaging, quantification, structure mapping, and computational modelling are presented and discussed. The stimulating mix of investigators has inspired novel approaches and collaborative studies leading to significant discoveries and establishing this as the leading conference in the field.

Session Topics:
• RNA processing and RNP dynamics
• RNA transport mechanisms
• Translational control mechanisms
• non-coding RNAs and RNA scaffolds
• Local translation and synaptic plasticity
• New technological frontiers in RNA biology
• RNA localization and developmental decisions

Speakers:
Susan Ackerman, UC San Diego Medical School Claudia Bagni, University of Lausanne Steven Block, Stanford University Fulvia Bono, Max Planck Institute for Developmental Biology Simon Bullock, MRC Laboratory of Molecular Biology Ilan Davis, University of Oxford Elizabeth Gavis, Princeton University Christine Holt, University of Cambridge V. Narry Kim, Seoul National University Ruth Lehmann, Skirball Institute of Biomolecular Medicine Howard Lipshitz, University of Toronto Paul Macdonald, The University of Texas at Austin Ian MacRae, Scripps, La Jolla, CA Kelsey Martin, UCLA Christine Mayr, Memorial Sloan Kettering Cancer Center Steven McKnight, UT Southwestern Medical Center Melissa Moore, Moderna Therapeutics Kimberly Mowry, Brown University Dierk Niessing, LMU Roy Parker, University of Colorado Boulder Lori Passmore, MRC Laboratory of Molecular Biology Laura Ranum, University of Florida Joel Richter, University of Massachusetts Medical School Erin Schuman, Max Planck Institute for Brain Research Geraldine Seydoux, Johns Hopkins School of Medicine Robert H. Singer, Albert Einstein College of Medicine Nahum Sonnenberg, McGill University Daniel St Johnston, The Gurdon Institute William Theurkauf, University of Massachusetts Medical School Jernej Ule, The Francis Crick Institute

Scientific Organizers:
Elena Conti, Max-Planck Institute of Biochemistry, Martinsried, Germany Anne Ephrussi, EMBL Heidelberg, Germany William Theurkauf, University of Massachusetts Medical School, USA

EMBL Course: Digital PCR

Bizouarn, D. Dewolf, J. Dreyer-Lamm

Real-time PCR has been adopted as the gold standard for nucleic acid target quantification in genomics research and is increasingly used for clinical analysis. However, there are some applications, such as precise measurement of copy number variation, low-abundance sequence detection, detection of rare mutations, including distinguishing rare sequences in tumours, and low-level gene expression analysis, where real-time PCR shows limitations. Digital PCR overcomes those limitations by enabling researchers to directly quantify nucleic acids, without the need for a standard curve, and provides higher precision than real-time PCR.

http://www.embl.de/training/events/2017/PCR17-01/index.html

18th Annual RiboClub Meeting

RNA scientists in Sherbrooke have organized the 18th RiboClub Meeting to be held in Orford at Hotel Chéribourg (in the vicinity of Sherbrooke, Quebec, Canada) on September 19th – 21st. This year the meeting is organized in partnership with the Swiss National Center of Competence in RNA & Disease.

The program includes keynote lectures by Peter Sarnow and Jack Szostak, poster sessions and over 25 invited speakers on plenary sessions that will include ribosome biogenesis and diversity, co-transcriptional RNA processing, RNP structure and function, RNA regulation in prokaryotes, detection and function of RNA structural motifs, splicing biodiversity and detection and function of small nucleolar RNA. The flavor of the year is “RNPs: the Good, the Bad and the Ugly. Insights into RNA-protein complex assembly and function in health and disease”.  Additional talks will be selected from submitted abstracts.

Registration and abstract deadline are until June 30, but late registration is accepted until September 2nd.

http://www.riboclub.org/cgi-bin/OpeningSession/index.pl?page=opening_session&year=2017

The RiboClub Society, in collaboration with the RNA Society, has set aside a limited amount of funds to provide travel fellowships for graduate students and postdoctoral fellows who otherwise would not be able to attend the meeting for financial reasons. If you wish to apply for a fellowship, please fill the pdf form at our web site and send it as file attachment by email to fellowship@nullriboclub.org . The application needs to be submitted before June 1st and the results will be sent to applicants by mid-June.

Looking forward to welcoming you in Orford next September.

EMBL Course: Whole Transcriptome Data Analysis

Benes, R. Calogero

The course participants will use BioConductor software and Illumina BaseSpace Cloud apps. R-coding skills and deep knowledge of statistics are not necessary for attendance because most analyses will be performed with OneChannelGUI (a graphical interface to a series of BioConductor tools, which enables handling microarray data analysis as well as RNA-seq data without requiring programming skills). Computers for hands-on exercises will be provided along with demo data sets. Upon request, participants could bring along their own data to analyse.

Audience

This course was developed for biologists as the intended audience. Basic knowledge of massively parallel sequencing (MPS) is desirable.

http://www.embl.de/training/events/2017/DAT17-02/index.html